Skip to main content

Treatment of Vasovagal Syncope: Counseling, Drugs, and Counter-Pressure Maneuvers

  • Chapter
  • First Online:
Vasovagal Syncope

Abstract

Transient loss of consciousness is a common symptom in the general population; it is estimated that approximately 40 % individuals will faint at least once in their lifetime. Vasovagal syncope (VVS), characterized by paroxysmal reflex-mediated hypotension associated with bradycardia, is the most common of the neurally mediated syncopal syndromes. The neurally mediated vasovagal reflex is caused by a rapid increase in vagal tone, which results in bradycardia or asystole, associated with hypotension, caused by the reduction in peripheral sympathetic activity, leading to systemic vasodilation with consequent global cerebral hypoperfusion and loss of consciousness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ammirati F, Colivicchi F, Velardi A et al (2001) Prevalence and correlates of syncope related traumatic injuries in vasovagal fainters. Ital Heart J 2:38–41

    CAS  PubMed  Google Scholar 

  2. Soteriades ES, Evans JC, Larson MG et al (2002) Incidence and prognosis of syncope. N Engl J Med 347:878–885

    Article  PubMed  Google Scholar 

  3. Moya A, Sutton R, Ammirati F et al (2009) Guidelines for the diagnosis and management of syncope (version 2009). The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA) and Heart Rhythm Society (HRS). Eur Heart J 30:2631–2671

    Article  PubMed Central  PubMed  Google Scholar 

  4. Schroeder C, Bush V, Norcliffe L et al (2002) Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation 106:2806–2811

    Article  PubMed  Google Scholar 

  5. Brignole M, Croci F, Menozzi C et al (2002) Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 40:2053–2059

    Article  PubMed  Google Scholar 

  6. Krediet CT, van Dijk N, Linzer M et al (2002) Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 106:1684–1689

    Article  PubMed  Google Scholar 

  7. van Dijk N, Quartieri F, Blanc JJ et al (2006) PC-Trial Investigators. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol 48:1652–1657

    Article  PubMed  Google Scholar 

  8. Morillo CA, Leitch JW, Yee R et al (1993) A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22:1843–1848

    Article  CAS  PubMed  Google Scholar 

  9. Lee TM, Su SF, Chen MF et al (1996) Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 78:480–482

    Article  CAS  PubMed  Google Scholar 

  10. Raviele A, Brignole M, Sutton R et al (1999) Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 99:1452–1457

    Article  CAS  PubMed  Google Scholar 

  11. Brignole M, Menozzi C, Gianfranchi L et al (1992) A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 70:339–342

    Article  CAS  PubMed  Google Scholar 

  12. Madrid A, Ortega I, Rebollo GJ et al (2001) Lack of efficacy of atenolol for the prevention of neurally-mediated syncope in highly symptomatic population: a prospective double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 37:554–557

    Article  CAS  PubMed  Google Scholar 

  13. Ventura R, Maas R, Zeidler D et al (2002) A randomized and controlled pilot trial of β-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 25:816–821

    Article  PubMed  Google Scholar 

  14. Sheldon R, Connolly S, Rose S et al (2006) Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113:1164–1170

    Article  PubMed  Google Scholar 

  15. Ward CR, Gray JC, Gilroy JJ et al (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79:45–49

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Perez-Lugones A, Schweikert R, Pavia S et al (2001) Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 12:935–938

    Article  CAS  PubMed  Google Scholar 

  17. Romme JJ, van Dijk N, Go-Schon IK et al (2011) Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Europace 13:1639–1647

    Article  PubMed  Google Scholar 

  18. Salim MA, Di Sessa TG (2005) Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol 45:484–488

    Article  CAS  PubMed  Google Scholar 

  19. Di Girolamo E, Di Iorio C, Sabatini P et al (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33:1227–1230

    Article  PubMed  Google Scholar 

  20. Theodorakis GN, Leftheriotis D, Livanis EG et al (2006) Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace 8:193–198

    Article  PubMed  Google Scholar 

  21. Benditt DG, Fahy GJ, Lurie KG et al (1999) Pharmacotherapy of neurally mediated syncope. Circulation 100:1242–1248

    Article  CAS  PubMed  Google Scholar 

  22. Guzman JC, Armaganijan LV, Morillo CA (2013) Treatment of neurally mediated reflex syncope. Cardiol Clin 31:123–129

    Article  PubMed  Google Scholar 

  23. Scott WA, Pongiglione G, Bromberg BI et al (1995) Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76:400–402

    Article  CAS  PubMed  Google Scholar 

  24. Sheldon R, Morillo CA, Krahn A et al (2011) A randomized clinical trial of fludrocortisone for the prevention of vasovagal syncope (POST2). Can J Cardiol 27:S335–S336

    Article  Google Scholar 

  25. Raj SR, Faris PD, McRae M et al (2012) Rationale for the prevention of syncope trial IV: assessment of midodrine. Clin Auton Res 22:275–280

    Article  PubMed Central  PubMed  Google Scholar 

  26. Di Girolamo E, Di Iorio C, Leonzio L et al (1999) Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 100:1798–1801

    Article  PubMed  Google Scholar 

  27. Ector H, Reybrouck T, Heidbuchel H et al (1999) Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin Electrophysiol 21:193–196

    Article  Google Scholar 

  28. Foglia-Manzillo G, Giada G, Gaggioli G et al (2004) Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace 6:199–204

    Article  PubMed  Google Scholar 

  29. Tan MP, Newton JL, Chadwick TJ et al (2010) Home orthostatic training in vasovagal syncope modifies autonomic tone: results of a randomized, placebo-controlled pilot study. Europace 12:240–246

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fabrizio Ammirati .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ammirati, F., Danisi, N., Romano, M. (2015). Treatment of Vasovagal Syncope: Counseling, Drugs, and Counter-Pressure Maneuvers. In: Alboni, P., Furlan, R. (eds) Vasovagal Syncope. Springer, Cham. https://doi.org/10.1007/978-3-319-09102-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09102-0_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09101-3

  • Online ISBN: 978-3-319-09102-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics